Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Zevra Therapeutics to Present at the Citizens Life Sciences Conference
-
Habit Celebrates Third Restaurant Launch in Torrance
-
Stabilization Notice - Pre Stab - Eutelstat Communications
-
Avista Corp. Reports 2025 Financial Results, Initiates 2026 Utility Earnings Guidance
-
Celldex Completes Enrollment in Global Phase 3 Studies (EMBARQ-CSU1 and EMBARQ-CSU2) of Barzolvolimab in Chronic Spontaneous Urticaria
-
Astec Reports Fourth Quarter and Full Year 2025 Results
-
EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026
-
Coppernico Completes Gravity and Magnetic Surveys and Refines Large Skarn-Porphyry Targets
-
NexGold Intersects 9.30 g/t Gold Over 11.0 Metres and 2.31 g/t Gold Over 21.5 Metres at the Goldlund Deposit, Ontario
-
Presenting on Emerging Growth Conference 90 Day 2 on February 26; Register to live stream
-
Sable Samples Up to 1.36% Cu at new “Zorro North” Target within the Zorro Project, San Juan, Argentina
-
Canterra Minerals Extends Lundberg Deposit with 86m of 0.91% CuEq at Buchans Project, Newfoundland
-
U.S. Energy Corp. Highlights Integrated Platform in New Investor Presentation and Emerging Growth Conference Appearance
-
Xali Gold Receives Green Light from Community, Pico Machay Gold Project in Peru
-
Inaugural Responsible Resource Leadership Forum underscores Indigenous Involvement in Canada’s Mining Development
-
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
Verifone and Unzer Expand Strategic Partnership to Empower Merchants with Unified Payment Ecosystem
-
WeShop Helps Pet Lovers Turn Everyday Pet Spending into Ownership with Chewy and PetSmart
-
Spring Valley Acquisition Corp. IV Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on or About March 2, 2026
-
Aura Biosciences to Participate in Upcoming Investor Conferences
-
Tonix Pharmaceuticals to Participate in Two Investor Conferences in March
-
Upstream Bio to Participate in Upcoming March Investor Conferences
-
Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
-
Dmitry Shubov Consulting Attends Startups & Operators Pitch Night — Dubai, Connecting With Founders
-
Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day
-
Amarin Reports Fourth Quarter and Full Year 2025 Financial Results
-
ODDITY Tech Reports Record Full Year 2025 Results
-
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PE
-
Dmitry Shubov Consulting Attends Startups & Operators Pitch Night — Dubai, Connecting With Founders
-
Photronics Reports First Quarter Fiscal 2026 Results
-
Ovid Therapeutics to Participate in Upcoming Investor Conferences
-
Amplify CWP International Enhanced Dividend Income ETF (IDVO) Surpasses $1 Billion in Assets
-
Istios Health Expands into Virtual Nephrology Care, Announces Strategic Partnership with Penn Highlands Healthcare
-
Breakthrough Shown to Cut Dementia Risk, Now Found to Help Repair Brain Injuries
-
Gray Media To Launch New Daily Program Aging Untold
-
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
-
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
At Joint Veterans’ Affairs Hearing, Blue Star Families’ Dr. Lindsay Knight Highlights Transition Risks and Evidence-Based Suicide Prevention Solutions
-
Aquestive Therapeutics to Participate in Upcoming March Investor Conferences
-
GXO announces partnership with Hunkemöller in the Netherlands
-
OTC Markets Group Welcomes RFA Financial Inc. to OTCQX
-
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
-
Balchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
-
Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2025
-
BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores
-
George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia
-
Immunocore reports fourth quarter and full year 2025 financial results and provides a business update
-
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
-
Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia

